|
[1]HALL TC,CARCEA G,METCAFE M,et al.Management of acute non-cirrhotic and non-malignant portal vein thrombosis:a systematic review[J].World J Surg,2011,35(11):2510-2520.
|
|
[2]JAMES AW,RABL C,WESTPHALEN AC,et al.Portomesenteric venous thrombosis after laparoscopic surgery:a systematic literature review[J].Arch Surg,2009,144(6):520-526.
|
|
[3]AMITRANO L,GUARDASCIONE MA,BRANCACCIO V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J].J Hepatol,2004,40(5):736-741.
|
|
[4]CONDAT B,PESSIONE F,DENNINGER HM,et al.Recent portal or mesenteric venous thrombosis:increased recognition and frequent recanalization on anticoagulant therapy[J].Hepatology,2000,32(3):466-470.
|
|
[5]HANDA P,CROWTHER M,DOUKETIS JD.Portal vein thrombosis:a Clinician-Oriented and practical review[J].Clin Appl Thromb Hemost,2013,20:498-506.
|
|
[6]BATTISTELLI S,CORATTI F,GORI T.Porto-spleno-mesenteric venous thrombosis[J].Int Angiol,2011,30(1):1-11.
|
|
[7]CONG YL,WEI YX,ZHANG LW,et al.The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores[J].Chin J Hepatol,2005,13(1):31-34.(in Chinese)丛玉隆,魏玉香,张立文,等.肝硬化患者凝血、抗凝及纤溶指标的变化与Child-Pugh分级的关系[J].中华肝脏病杂志,2005,13(1):31-34.
|
|
[8]TRIPODI A,MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med,2011,365(2):147-156.
|
|
[9]LU XM,WANG ZN,YANG J.Significance of molecular markers of prethrombotic state in monitoring portal vein thrombosis in patients with liver cirrhosis[J].J Clin Hepatol,2015,31(3):404-406.(in Chinese)卢晓敏,王振宁,杨军.肝硬化患者血栓前状态分子标志物对门静脉血栓形成的监测意义[J].临床肝胆病杂志,2015,31(3):404-406.
|
|
[10]FRANCOZ C,BELLGHITI J,VILGRAIN V,et al.Splanchnic vein thrombosis in candidates for liver transplantation:usefulness of screening and anticoagulatio[J].Gut,2005,54(5):691-697.
|
|
[11]MEI B,ZHENG K,CHEN XP.Relationship between platelets membrane glucoprotein CD62P with thrombosis of portal vein after devascularization operation[J].Acta Med Univ Sci Technol Huazhong,2006,35(4):548-549.(in Chinese)梅斌,郑凯,陈孝平.断流术后门静脉血栓形成与血小板膜蛋白CD62P的关系[J].华中科技大学学报:医学版,2006,35(4):548-549.
|
|
[12]OISON MM,LLADA PB,APELGREN KN.Portal vein thrombosis[J].Surg Endosc,2003,17(8):1322-1325.
|
|
[13]CHEN GP,WANG JY,YU FH,et al.Expression of platelet membrane protein CD62P in patients with hepatic cirrhosis[J].Med JQilu,2013,28(5):441-442.(in Chinese)陈冠平,王家银,于凤华,等.肝硬化病人血小板膜蛋白CD62P表达及临床意义[J].齐鲁医学杂志,2013,28(5):441-442.
|
|
[14]WANG GP,ZHANG ZC,XIA CM.Influence of endoscopic therapy on tissue factor pathway inhibitor and coagulation function in patients with gastrointestinal bleeding[J].J Radioimmunol,2013,26(4):521-522.(in Chinese)王国平,张忠臣,夏晨梅.内镜治疗对消化道出血患者组织因子途径抑制剂及凝血功能的影响[J].放射免疫学杂志,2013,26(4):521-522.
|
|
[15]PONZIANI FR,ZOCCO MA,CAMPANALE C,et al.Portal vein thrombosis:insight into physiopathology,diagnosis,and treatment[J].World J Gastroenterol,2010,16(2):143-155.
|
|
[16]AMITRANO L,BRANCACCIO V,GUARDASCIONE MA,et al.Inherited coagulation disorders in cirrhotic patients with pontal vein thrombosis[J].Hepatology,2000,31(2):345-348.
|
|
[17]de BRUIJNE EL,DARWISH MS,de MAAT MP,et al.Genetic variation in thrombin-activatable fibrinolysis inhibitor(TAFI)is associated with the risk of sp Ianchnic vein thrombosis[J].Thromb Haemost,2007,97(2):181-185.
|
|
[18]MARLINELLI I,PRIMIGNANI M,AGHEMO A,et al.High levels of factor VIII and risk of extra-hepatic portal vein obstruction[J].J Hepatol,2009,50(5):916-922.
|
|
[19]KUANG DP,YANG WZ.Research advances in liver cirrhosis complicated by portal vein thrombosis[J].Chin Hepatol,2013,18(2):119-121.(in Chinese)匡大鹏,杨文卓.肝硬化合并门静脉血栓形成的研究进展[J].肝脏,2013,18(2):119-121.
|
|
[20]WU XF,LU Y,LIU JZ,et al.Diagnostic value of ultrasound findings in postoperative portal vein thrombosis in patients with portal hypertension[J].Guide China Med,2014,12(7):131-132.(in Chinese)吴小凤,陆洋,刘继章,等.超声对门静脉高压症术后并发门静脉系统血栓的诊断价值[J].中国医药指南,2014,12(7):131-132.
|
|
[21]LAI W,LU SC,LI GY,et al.Anticoagulation therapy prevents portal-splenic vein thrombosis after splenec-tomy with gastroesophageal devascularization[J].World J Gastroenterol,2012,18(26):3443-3450.
|
|
[22]SENZOLO M,M SARTORI T,ROSSETTO V,et al.Prospective evaluation of anticoagulation and transjugular intrahepatic portosys temic shunt for the management of portal vein thrombosis in cirrhosis[J].Liver Int,2012,32(6):919-927.
|
|
[23]ENGLESBE MJ,SCHAUBEL DE,CAI S,et al.Portal vein thrombosis and liver transplant survival benefit[J].Liver Transplantation,2010,16(8):999-1005.
|
|
[24]DOENECKE A,TSUI TY,ZUELKE C,et al.Pre-existent portal vein.thrombosis in liver transplantation:influence of pre-operative.disease severity[J].Clin Transplant,2010,24(1):48-55.
|
|
[25]FRANCOZ C,DOMINIQUE V,FRANCOIS D.Portal vein throm-bosis,cirrhosis,and liver transplantation[J].J Hepatol,2012,57(1):203-212.
|
DownLoad: